Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACONW

Aclarion (ACONW)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACONW
DateTimeSourceHeadlineSymbolCompany
02/12/202422:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONWAclarion Inc
28/11/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
23/11/202408:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONWAclarion Inc
22/11/202400:00GlobeNewswire Inc.Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNASDAQ:ACONWAclarion Inc
15/11/202405:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONWAclarion Inc
14/11/202407:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACONWAclarion Inc
09/11/202408:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
05/11/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
05/11/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
05/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
04/11/202422:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACONWAclarion Inc
26/10/202408:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONWAclarion Inc
25/10/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
16/10/202407:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACONWAclarion Inc
12/10/202407:36Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACONWAclarion Inc
12/10/202407:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
10/10/202422:00GlobeNewswire Inc.Aclarion to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ACONWAclarion Inc
02/10/202406:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
27/09/202420:57GlobeNewswire Inc.Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesNASDAQ:ACONWAclarion Inc
25/09/202406:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
25/09/202406:54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACONWAclarion Inc
24/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
24/09/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
20/09/202407:02Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ACONWAclarion Inc
12/09/202420:57GlobeNewswire Inc.Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesNASDAQ:ACONWAclarion Inc
10/09/202420:57GlobeNewswire Inc.Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialNASDAQ:ACONWAclarion Inc
05/09/202420:57GlobeNewswire Inc.Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketNASDAQ:ACONWAclarion Inc
29/08/202420:57GlobeNewswire Inc.Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyNASDAQ:ACONWAclarion Inc
21/08/202421:57GlobeNewswire Inc.Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment PlansNASDAQ:ACONWAclarion Inc
15/08/202423:48GlobeNewswire Inc.Aclarion to Present at August 20th Virtual Investor Summit Microcap EventNASDAQ:ACONWAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACONW